Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Probing the Dry Weight (DW) by Bioimpedance (BIA): Which is the Gold Standard Between Clinical DW and BIA DW?

NCT02606955 is registered in ClinicalTrials.gov with Miulli General Hospital as lead sponsor.

NCT NCT02606955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02606955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Probing the Dry Weight (DW) by Bioimpedance (BIA): Which is the Gold Standard Between Clinical DW and BIA DW?
Lead sponsor
Miulli General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2015
Completion date
December 31, 2016
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

uremia